Literature DB >> 4142035

The possible viral aetiology of disseminated sclerosis.

F Cathala, P Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4142035      PMCID: PMC1347263     

Source DB:  PubMed          Journal:  J Clin Pathol Suppl (R Coll Pathol)        ISSN: 0144-0330


× No keyword cloud information.
  59 in total

1.  Viruses and the neuroglia with special reference to scrapie, kuru and disseminated sclerosis.

Authors:  H E Webb
Journal:  Proc R Soc Med       Date:  1967-07-07

2.  Cell-fusing activity of visna virus particles.

Authors:  D H Harter; P W Choppin
Journal:  Virology       Date:  1967-02       Impact factor: 3.616

3.  Multiple sclerosis and scrapie.

Authors:  G Dick; J J McAlister; F McKeown; A M Campbell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-12       Impact factor: 10.154

4.  Measles virus: a causative agent in multiple sclerosis?

Authors:  E Pette
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

Review 5.  Relation of immune response to development of central nervous system lesions in virus infections of man.

Authors:  H E Webb; C E Smith
Journal:  Br Med J       Date:  1966-11-12

6.  Viral antibody in the cerebrospinal fluid and serum of multiple sclerosis patients.

Authors:  J K Clarke; D S Dane; G W Dick
Journal:  Brain       Date:  1965-12       Impact factor: 13.501

7.  Multiple sclerosis and vaccination.

Authors:  H Miller; W Cendrowski; K Shapira
Journal:  Br Med J       Date:  1967-04-22

8.  Transmission experiments with multiple sclerosis: an interim report.

Authors:  E J Field
Journal:  Br Med J       Date:  1966-09-03

9.  Electron microscopic features of multiple sclerosis lesions.

Authors:  O Périer; A Grégoire
Journal:  Brain       Date:  1965-12       Impact factor: 13.501

10.  Measles antibodies in patients with multiple sclerosis.

Authors:  J M Adams
Journal:  Neurology       Date:  1967-07       Impact factor: 9.910

View more
  9 in total

1.  Purification of measles virus and characterization of subviral components.

Authors:  K C Stallcup; S L Wechsler; B N Fields
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

Review 2.  [Slow latent chronic or recurrent viral infections of the nervous system in man].

Authors:  F Cathala
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

3.  Early sterile autopsy in etiological studies on multiple sclerosis.

Authors:  H J Bauer; V ter Muelen; H Koprowski; A Argyrakis; H Orthner
Journal:  J Neurol       Date:  1975       Impact factor: 4.849

4.  Elevated antibody levels against measles virus P protein in sera of patients with multiple sclerosis.

Authors:  S L Wechsler; H C Meissner
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

5.  Measles virus-specific antibodies and immunoglobulin M antiglobulin in sera from multiple sclerosis and rheumatoid arthritis patients.

Authors:  P V Shirodaria; K B Fraser; M Armstrong; S D Roberts
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

6.  IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages.

Authors:  Jessica J Ashbaugh; Roberta Brambilla; Shaffiat A Karmally; Cecilia Cabello; Thomas R Malek; John R Bethea
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

7.  Intracellular synthesis of measles virus-specified polypeptides.

Authors:  S L Wechsler; B N Fields
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

8.  Measles virus-specified polypeptide synthesis in two persistently infected HeLa cell lines.

Authors:  S L Wechsler; R Rustigian; K C Stallcup; K B Byers; S H Winston; B N Fields
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

Review 9.  Chronic viral infections of the central nervous system: Aspects specific to multiple sclerosis.

Authors:  P Giraudon; A Bernard
Journal:  Rev Neurol (Paris)       Date:  2009-08-04       Impact factor: 2.607

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.